Polymer-based broad spectrum antivirals show activity against Zika, Ebola, HIV-1, the Herpes simplex virus, and now, SARS-CoV-2.

Polymer-based broad spectrum antivirals show activity against Zika, Ebola, HIV-1, the Herpes simplex virus, and now, SARS-CoV-2.
Brains of mice controlled using light-emitting nanoparticles in a proof-of-concept study to show wireless neuromodulation.
A non-surgical option for women who suffer from endometriosis, this nanoparticle therapy shows promising preliminary results.
Copper’s ability to hinder the motility of sperm makes it an ideal contraceptive, and researchers have now formulated it into a spermicide.
A 3D hydrogel model provides key insights into how cells sense and respond to elements of their environment.
A new proof-of-concept cancer therapy safely and accurately destroys cancerous cells with precisely delivered heat.
A new device setup enables an interface between biomolecules and electronic materials for biohybrid electronics.
An extensive library of over one million cells could pave the way for new and repurposed treatments for a number of autoimmune diseases.
Using nanoparticles fitted with ACE2 receptors, researchers hope to lure SARS-CoV-2 away from healthy cells to inhibit the virus and treat infection.
A pioneer of advanced healthcare materials, Nicholas Peppas continues to innovate in the fields of healthcare materials and drug delivery.